Home » Topics » BioWorld Science

BioWorld Science
RSS

NCX-911 may benefit ED patients with dysfunctional endogenous NO production

June 18, 2004

Treatment options for restless legs syndrome

June 18, 2004

Dopamine D4 receptor agonist ABT-724 may offer safe and effective treatment of erectile dysfunction

June 18, 2004

GPC Biotech achieves significant progress in anticancer drug programs during first quarter

June 18, 2004

Novel fructose 1,6-bisphosphatase inhibitor lowers blood glucose in vivo

June 18, 2004

Polyvalent vaccine reported to improve survival in advanced melanoma

June 18, 2004

Bavarian Nordic highlights Imvamune progress

June 18, 2004

Clinical response found with eculizumab in rheumatoid arthritis

June 17, 2004

Preliminary data on the efficacy of epratuzumab in SLE

June 17, 2004

New monoamine reuptake inhibitors developed at NeuroSearch

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...